Sign Up Today and Learn More About ImmunOs Therapeutics Stock
Invest in or calculate the value of your shares in ImmunOs Therapeutics or other pre-IPO companies through EquityZen's platform.
ImmunOs Therapeutics Stock (IOST)
ImmunOs Therapeutics is a clinical-stage biotechnology company.
About ImmunOs Therapeutics Stock
Founded
2014
Industries
Software, Artificial Intelligence, Data and Analytics
ImmunOs Therapeutics Press Mentions
Stay in the know about the latest news on ImmunOs Therapeutics
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
pharmiweb • Oct 20, 2025
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
globenewswire • Oct 20, 2025
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
biospace • Oct 20, 2025
Combination medicaments comprising hla fusion proteins
patents • May 04, 2025
Pharmaceutical compositions comprising hla fusion proteins
patents • May 04, 2025
ImmunOs Therapeutics Management
Leadership team at ImmunOs Therapeutics
Board Member
Daniel Vasella
Board Member
Steven Tregay
Join now and verify your accreditation status to gain access to:
- ImmunOs Therapeutics Current Valuation
- ImmunOs Therapeutics Stock Price
- ImmunOs Therapeutics Management
- Available deals in ImmunOs Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- ImmunOs Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- ImmunOs Therapeutics Revenue and Financials
- ImmunOs Therapeutics Highlights
- ImmunOs Therapeutics Business Model
- ImmunOs Therapeutics Risk Factors
- ImmunOs Therapeutics Research Report from SACRA Research
Trading ImmunOs Therapeutics Stock
How to invest in ImmunOs Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like ImmunOs Therapeutics through EquityZen funds. These investments are made available by existing ImmunOs Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ImmunOs Therapeutics stock?
Shareholders can sell their ImmunOs Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
